Recent News

• 02.14.2025 - Entero Therapeutics Appoints Richard Paolone as CEO
• 02.07.2025 - Entero Therapeutics Secures $2 Million Revolving Loan; Appoints Three New Board Members

Recent Filings

• 02.14.2025 - 8-K Current report
• 02.14.2025 - EX-99.1 EX-99.1
• 02.13.2025 - 3 Initial statement of beneficial ownership of securities
• 02.13.2025 - 3 Initial statement of beneficial ownership of securities
• 02.13.2025 - 3 Initial statement of beneficial ownership of securities
• 02.06.2025 - 8-K Current report
• 01.13.2025 - 8-K Current report
• 01.08.2025 - 4 Statement of changes in beneficial ownership of securities
• 11.27.2024 - 8-K Current report
• 11.13.2024 - EX-99.1 EX-99.1